Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years

PARSIPPANY, N.J., June 5, 2000 -- Aventis Pharmaceuticals announced today that Allegra® (fexofenadine HCl) 30-mg tablets, twice daily (BID), are now available by prescription for the relief of seasonal allergic rhinitis (SAR) and chronic idiopathic urticaria (CIU) in children aged 6 to 11 years.

"Seasonal allergies affect up to six million children in the United States," said Eli Meltzer, M.D., of the Allergy and Asthma Group and Research Center, San Diego, California and lead investigator of the clinical study, Safety of Fexofenadine HCl in Children Treated for Seasonal Allergic Rhinitis. "Allegra 30-mg tablets offer physicians a safe, nonsedating allergy treatment that can help in the management of children's seasonal allergies."

In a study of 411 pediatric patients, Allegra 30-mg tablets BID significantly reduced total symptom scores compared to placebo and was well tolerated among children aged 6 to 11 years. Such allergy symptoms, including runny nose, itchy, watery, red eyes, sneezing and itchy nose, palate and throat can hinder the enjoyment of outdoor activities that children like to pursue.

Allegra 30-mg tablets are nonchewable and are smaller than a chocolate chip. This pediatric dose is an addition to the Allegra family of products currently available for patients 12 and older, including Allegra® (fexofenadine HCl) 60-mg capsules, Allegra-D® (fexofenadine HCl 60 mg/pseudoephedrine HCl 120 mg) Extended-Release Tablets and Allegra® (fexofenadine HCl) 180-mg tablets.

Side-Effect Profile
In clinical trials, adverse events with Allegra 30-mg tablets were similar to placebo. The most commonly reported with Allegra 30-mg tablets and placebo in seasonal allergic rhinitis patients 6-11 years are headache (7.2% vs. 6.6%), upper respiratory tract infection (4.3% vs. 1.7%), coughing (3.8% vs. 1.3%), and accidental injury (2.9% vs. 1.3%).

Allegra 60-mg capsules are well tolerated with side effects similar to placebo.

Contact: Charles F. Rouse III
Porter Novelli

Page: 1 2 3

Related medicine news :

1. Aventis Pasteur ready to meet nations needs for tetanus and diphtheria vaccine
2. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
3. Aventis Pasteur statement on HVTN 501 decision
4. Millennium, Aventis Pharma form novel alliance
5. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
6. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
7. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
8. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
9. Pharmaceuticals and personal care products
10. Nortran Pharmaceuticals Inc. and Hoechst Marion Roussel announce collaborativeagreement
11. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis

Post Your Comments:

(Date:12/6/2018)... ... December 06, 2018 , ... HMP, a leader in ... (PACS). The meeting will take place May 9–10, 2019, and will be co-located ... San Antonio, Texas. , PACS is uniquely designed to provide nurses with the ...
(Date:12/6/2018)... ... 06, 2018 , ... Pulse8’s Senior Director of Quality Products, ... Blue Shield of Kansas City, will present on “Boosting Stars Scores by Better ... at the Fairmont Grand Del Mar in San Diego, California. , During ...
(Date:12/5/2018)... ... December 05, 2018 , ... ... Precision device is setting a new standard as the premier FDA-cleared microneedling device. ... Each year this award is presented at the renowned Aesthetics Awards to products ...
(Date:12/5/2018)... ... December 05, 2018 , ... A well-known name in the ... to the masses. Wellbeats , which has delivered on-demand, virtual fitness programming to ... consumer app. Available now in the Apple App Store, the Wellbeats app is ...
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced Clinical, ... services, announced its new office location in Paris, France during the Partnerships in ... trial operations in Europe and additional in-country personnel. , “The new office broadens ...
Breaking Medicine News(10 mins):
(Date:12/8/2018)... HILLS, Calif. (PRWEB) , ... December 08, 2018 ... ... families of fallen military heroes. On December 8, 2018, the Gary Sinise Foundation’s ... fallen and their surviving parent or guardian. This therapeutic retreat will offer fun ...
(Date:12/6/2018)... ... 06, 2018 , ... It’s easy to get sick during cold and flu season, and when ... someone with the flu can spread it to others up to about 6 feet away. ... flu cough, sneeze or talk. While most people recover from the flu within seven to ...
(Date:12/6/2018)... ... December 06, 2018 , ... Every day, and especially during the holidays, ... best way to clean up (and throw away) bacteria-filled messes, and to prevent germs ... which can spread germs around other kitchen surfaces and increase the odds of cross-contamination. ...
Breaking Medicine Technology:
Cached News: